Fiasp and Ibritumomab Intravenous
Determining the interaction of Fiasp and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Fiasp Injection
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fiasp-Ibritumomab Tiuxetan
- Fiasp-Ibrutinib
- Fiasp-Ibrutinib Capsules
- Fiasp-Ibrutinib Tablets
- Fiasp-Ibu
- Fiasp-IBU Tablets
- Ibritumomab Intravenous-Fiasp (Insulin Aspart (Cartridges & Prefilled Pens) (Fiasp))
- Ibritumomab Intravenous-Fiasp (Insulin Aspart (Vials) (Fiasp))
- Ibritumomab Intravenous-Fiasp (Insulin Aspart (Vials))
- Ibritumomab Intravenous-Fiasp FlexTouch
- Ibritumomab Intravenous-Fiasp Injection
- Ibritumomab Intravenous-Fiber Lax